rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Anthony Rosenberg

Director

Company insider

Files Form 4 as: Director, Cullinan Therapeutics; Director, Radius Health.

In numbers

Trades disclosed
21
Buys
0
Sells
2
Bought
$0
Sold
$72K
Companies
2
Companies where not an officer
2
First trade
2 Mar 2015
Last trade
16 Jun 2026
Last filed
18 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CGEM Cullinan TherapeuticsDirector · Biotechnology · last 16 Jun 20260 buys · 0 sells
Radius HealthDirector · last 26 Feb 20200 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Jun 2026filed 18 Jun 2026CGEM Cullinan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,319 at $0.00filing
16 Jun 2026filed 18 Jun 2026CGEM Cullinan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,319 at $0.00filing
12 Jun 2025filed 16 Jun 2025CGEM Cullinan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—38,513 at $0.00filing
26 Jun 2024filed 27 Jun 2024CGEM Cullinan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—15,806 at $0.00filing
8 Jun 2023filed 12 Jun 2023CGEM Cullinan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—18,450 at $0.00filing
22 Jun 2022filed 23 Jun 2022CGEM Cullinan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—16,475 at $0.00filing
16 Sep 2021filed 25 Mar 2022CGEM Cullinan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—7,800 at $0.00filing
26 Feb 2020filed 28 Feb 2020Radius HealthSEC FORM 4 Sold$33K1,815 at $17.95filing
20 Feb 2020filed 24 Feb 2020Radius Healthoption or derivativeSEC FORM 4 Code A—10,000 at $0.00filing
20 Feb 2020filed 24 Feb 2020Radius HealthSEC FORM 4 Code A—5,500filing
1 Jul 2019filed 3 Jul 2019Radius HealthSEC FORM 4 Sold$39K1,584 at $24.60filing
22 Feb 2019filed 26 Feb 2019Radius Healthoption or derivativeSEC FORM 4 Code A—10,000 at $0.00filing
22 Feb 2019filed 26 Feb 2019Radius HealthSEC FORM 4 Code A—5,500filing
13 Feb 2019filed 13 Feb 2019Radius Healthoption or derivativeSEC FORM 4 Code M—4,800 at $0.00filing
13 Feb 2019filed 13 Feb 2019Radius HealthSEC FORM 4 Code M—4,800filing
13 Feb 2018filed 15 Feb 2018Radius Healthoption or derivativeSEC FORM 4 Code A—8,800 at $0.00filing
13 Feb 2018filed 15 Feb 2018Radius Healthoption or derivativeSEC FORM 4 Code A—4,800 at $0.00filing
17 Feb 2017filed 22 Feb 2017Radius Healthoption or derivativeSEC FORM 4 Code A—27,500 at $0.00filing
24 May 2016filed 2 Jun 2016Radius Healthoption or derivativeSEC FORM 4 Code A—27,500 at $0.00filing
10 Feb 2016filed 12 Feb 2016Radius Healthoption or derivativeSEC FORM 4 Code A—27,500 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Jennifer MichaelsonChief Scientific Officer · Chief Scientific Officer at Cullinan Therapeutics, filing Form 4 there in the last year
Mary Kay FentonChief Financial Officer · Chief Financial Officer at Cullinan Therapeutics, filing Form 4 there in the last year
Jacquelyn L. SumerChief Legal Officer · Chief Legal Officer at Cullinan Therapeutics, filing Form 4 there in the last year
David D. MeekDirector · Director at Cullinan Therapeutics, filing Form 4 there in the last year
Mary ThistleDirector · Director at Cullinan Therapeutics, filing Form 4 there in the last year